Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1537-1544

  Kopydlowski, Karen M ^a   Salkowski, Cindy A ^a   Cody, M Joshua ^a   Van Rooijen, Nico ^b   Major, Jennifer ^c   Hamilton, Thomas A ^c   Vogel, Stefanie N ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL ISOLATION; CYTOKINE PRODUCTION; KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEPSIS;

ANIMALS; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; DOWN-REGULATION; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-10; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTE CHEMOATTRACTANT PROTEINS; RNA, MESSENGER;

EID: 0033179531     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Bone, R. C. 1993. Gram-negative sepsis: a dilemma of modern medicine. Clin. Microbiol. Rev. 6:57.
2. Dellinger, R., S. M. Opal, D. Rotrosen, A. F. Suffredini, and J. L. Zimmerman. 1997. From the bench to the bedside: the future of sepsis research. Chest 111:744.
3. Manthey, C. L., and S. N. Vogel. 1992. The role of cytokines in host response to endotoxin. Rev. Med. Microbiol. 3:72.
4. Morrison, D. C., R. L. Danner, C. A. Dinarello, S. Munford, C. Natanson, M. Pollack, J. J. Spitzer, R. J. Ulevitch, S. N. Vogel, and E. McSweegan. 1994. Bacterial endoloxins and pathogenesis of Gram-negative infections: current status and future direction. J. Endotoxin Res. 1:71.
5. Evans, G. F., Y. M. Snyder, L. D. Butler, and S. H. Zuckerman. 1989. Differential expression of interleukin-I and tumor necrosis factor in murine septic shock models. Circ. Shock 29:279.
6. Ghosh, S., R. D. Latimer, B. M. Gray, R. J. Harwod, and A. Oduro. 1993. Endotoxin-induced organ injury. Crit. Care Med. 21:S19.
7. Taub, D. D. 1996. Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev. 7:355.
8. Rollins, B. J. 1997. Chemokines. Blood 90:909.
9. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
10. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
11. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX(3)C motif. Nature 385:640.
12. Pan, Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J.-A. Gonzalo, J. Vath, M. Gosselin, J. Ma, B. Dussault, E. Woolf, G. Alperin, J. Culpepper, J. C. Gutierrez-Ramos, and D. Gearing. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611.
13. Clark-Lewis, I., C. Schumacher, M. Baggiolini, and B. Moser. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs: critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J. Biol. Chem. 266:23128.
14. Clark-Lewis, I., B. Dewald, T. Geiser, B. Moser, and M. Baggiolini. 1993. Platelet factor 4 binds to interleukin-8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad. Sci. USA 90:3574.
15. Bozic, C. R., L. F. Kolakowski, N. P. Gerard, C. Garcia-Rodriguez, C. von Uexkull-Guldenband, M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:6048.
16. Taub, D. D., A. R. Lloyd, K. Conlan, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
17. Taub, D. D., T. J. Sayers, C. R. D. Carter, and J. R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877.
18. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP-10 and Mig: structure, function and expression in activated T lymphocytes. J. Exp. Med. 184:963.
19. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27:4162.
20. Zisman, D. A., S. L. Kunkel, R. M. Stricter, W. C. Tsai, K. Bucknell, J. Wilkowski, and T. J. Standiford. 1997. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 99:2832.
21. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Stricter, and S. L. Kunkel. 1997. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65:3847.
22. VanOtteren, G. M., R. M. Stricter, S. L. Kunkel, R. Paine III, M. J. Greenberger, J. M. Danforth, M. D. Burdick, and T. J. Standiford. 1995. Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 154-1900.
23. Standiford, T. J., R. M. Stricter, N. W. Lukacs, and S. L. Kunkel. 1995. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155-2222.
24. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danforth, R. G. Kunkel, and R. M. Stricter. 1995. Macrophage inflammatory protein-1α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515.
25. Salkowski, C. A., G. Detore, A. Franks, M. C. Falk, and S. N. Vogel. 1998. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66:3569.
26. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, and biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6:2363.
27. van Rooijen, N., and A. Sanders. 1994. Liposome-mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174:83.
28. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, J. Potter, C. L. Furlonger, A. Narendran, H. Suzuki, P. Ohashi, C. J. Paige, T. Taniguchi, and T. W. Mak. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83.
29. Lakics, V., and S. N. Vogel. 1998. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in mutine macrophages. J. Immunol. 161:2490.
30. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
31. van Rooijen, N., and R. van Nieuwmegen. 1984. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate: an enzyme-histochemical study. Cell Tissue Res. 238:355.
32. van Rooijen, N., N. Kors, M. van de Ende, and C. D. Dijkstra. 1990. Depletion and repopulation of macrophage in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 260:215.
33. Salkowski, C. A., R. Neta, T. A. Wynn, G. Strassmann, N. van Rooijen, and S. N. Vogel. 1995. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J. Immunol. 155:3168.
34. Manthey, C. L., P. Y. Perera, C. A. Salkowski, and S. N. Vogel. 1994. Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol. 152:825.
35. Su, Y.-H., X.-T. Yan, J. E. Oakes, and R. N. Lausch. 1996. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type I corneal infection. J. Virol. 70:1277.
36. Barber, S. A., M. J. Fultz, C. A. Salkowski, and S. N. Vogel. 1995. Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63:601.
37. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
38. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
39. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
40. Salkowski, C. A., G. R. Detore, and S. N. Vogel. 1997. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect. Immun. 65:3239.
41. Kim, H. S., D. Armstrong, T. A. Hamilton, and J. M. Tebo. 1998. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J. Leukocyte Biol. 64:33.
42. Berkman, N., M. John, G. Roesems, P. J. Jose, P. J. Barnes, and K. F. Chung. 1995. Inhibition of macrophage inflammatory protein-1α expression by IL-10: differential sensitivities in human blood monocytes and alveolar macrophages. J. Immunol. 155:4412.
43. Sherry, B., M. Espinoza, K. R. Manogue, and A. Cerami. 1998. Induction of the chemokine β peptides, MIP-1α and MIP-1β, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines γ-IFN, IL-10-IL-4, and TGF-β. Mol. Med. 4:648.
44. Tebo, J. M., H. S. Kim, J. Gao, D. A. Armstrong, and T. A. Hamilton. 1998. Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon. Blood 92:4742.
45. Koerner, T. J., D. O. Adams, and T. A. Hamilton. 1987. Regulation of tumor necrosis factor (TNF) expression: interferon-γ enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages. Cell. Immunol. 109:437.
46. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S. W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 268:1908.
47. Bogers, W. M. J. M., R.-K. Stad, D. J. Janssen, N. van Rooijen, L. A. van Es, and M. R. Daha. 1991. Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells. Clin. Exp. Immunol. 86:328.
48. Freudenberg, M. A., D. Keppler, and C. Galanos. 1986. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitivity to endotoxin. Infect. Immun. 51:891.
49. Vogel, S. N., and M. M. Hogan. 1990. The role of cytokines in endotoxin-mediated host responses. In Immunophysiology: Role of Cells and Cytokines in Immunity and Inflammation. J. Oppenheim, and E. Shevach, eds. Oxford University Press, New York, p. 238.
50. Perera, P.-Y., C. L. Manthey, P. I. Stutz, J. Hildebrandt, and S. N. Vogel. 1993. Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials. Infect. Immun. 61:2015.
51. Moore, K. W., A. O'Garra, R. De Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
52. Ho, A. S., and K. W. Moore. 1994. Interleukin-10 and its receptor. Ther. Immunol. 1:173.
53. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
54. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med 177:547.
55. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267:23301.
56. Wang, P., P. Wu, J. C. Anthes, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83: 2678.
57. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton, 1992. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149:1666.
58. Kohler, J., D. Heumann, G. Garotta, D. LeRoy, S. Bailat, C. Barras, J. D. Baumgartner, and M. P. Glauser. 1993. IFN-γ involvement in the severity of gram-negative infections in mice. J. Immunol. 151:916.
59. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
60. Ohmori, Y., and T. Hamilton. 1994. IFN-γ selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J. Immunol. 153:2204.
61. Ohmori, Y., and T. A. Hamilton. 1995. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by 1FN-γ and TNF-α. J. Immunol. 154:5235.
62. Hayes, M. P., and K. Zoon. 1993. Priming of human monocytes for enhanced lipopolysaccharide responses: expression of α interferon, interferon regulatory factors, and tumor necrosis factor. Infect. Immun. 61:3222.
63. Pine, R., T. Decker, D. S. Kessler, D. E. Levy, and J. E. Darnell. 1990. Purification and cloning of interferon-stimulated gene factor 2 (ISGF-2): ISGF-2 (IRF-1) can bind to the promoters of both β interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10:2448.
64. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729.
65. Nelson, N., M. S. Marks, P. H. Driggers, and K. Ozato. 1993. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 13:588.
66. Tanaka, N., T. Kawakami, and T. Taniguchi. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:4531.
67. Ohmori, Y., S. Fukumoto, and T. A. Hamilton. 1995. Two structurally distinct κB sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J. Immunol. 155:3593.
68. Drew, P. D., G. Franzoso, K. G. Becker, V. Bours, L. M. Carlson, U. Siebenlist, and K. Ozato. 1995. NFκB and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15:1037.
69. Salkowski, C. A., K. Kopydlowski, J. Blanco, M. J. Cody, R. McNally, and S. N. Vogel. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163:1529.